Chief Scientific Officer
Gherici Hassaine: graduated from the University of Marseille, France, in 2001, with a Ph.D. in molecular biology. In the same year, Gherici joined Bio-Xtal, where he was responsible for the scientific development program, as well as leading the scientific aspects of a structural genomics collaboration with the University of Strasbourg (see above) started by Etienne. Gherici has previously worked at a biotechnology company, based in Switzerland, during which time he worked on the detection of cancer micro-cells. He joined Theranyx in 2012 as its CSO and has been since instrumental in the development of the platform and the recent discoveries of functional antibodies by the company.